THE SPREAD OF CORONAVIRUS INFECTION AROUND THE WORLD
Keywords:
incidence of COVID-19; incidence of SARSCoV-2; Etiology of COVID-19; Pathogenesis of COVID-19; coronavirus pandemic; clinical manifestations of coronavirus infection; the situation in the world.Abstract
On January 30, 2020, the World Health Organization (WHO) recognized the outbreak of coronavirus infection in China as a public health emergency of international importance. WHO Director General Tedros Adhanom Ghebreyesus said after a meeting of the emergency committee in Geneva, "I declare an international public health emergency due to the global outbreak of coronavirus." The article presents the current epidemiological indicators of COVID-19 for the territory of Primorsky Krai. The levels of morbidity and incidence of COVID-19 for the period from April 14, 2020 to May 14, 2020 have been determined. The etiology and pathogenesis of coronavirus infection are described. Clinical manifestations and risk factors of this infection have been noted. A review of the literature on the current situation in the world has been conducted.
References
Сборник методических рекомендаций, алгоритмов действий медицинских работников на различных этапах оказания помощи, чек-листов и типовых документов, разработанных на период наличия и угрозы дальнейшего распространения новой коронавирусной инфекции в Санкт-Петербурге. Версия 1,0 от17.04.2020. — СПб.; 2020. — 157 c. [доступ от 21.03.2012].
Мокрышева Н.Г., Галстян Г.Р., Киржаков М.А., и др. Пандемия COVID-19 и эндокринопатии // Проблемы эндокринологии. —2020. — Т.66. — №1. [Mokrysheva NG, Galstyan GR, Kirzhakov MA, et al. Pandemiya COVID-19 i endokrinopatii. Problemy endokrinologii. 2020;66(1). (In Russ.)].
Desailloud R, Hober D. Viruses and thyroiditis: an update. VirolJ.2009;6:5.
Kaiser UB, Mirmira RG, Stewart PM. Our response to COVID-19 as endocrinologists and diabetologists. J. Clin. Endocr. Metab. 2020;105 (5Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: management of hyper- and hypothyroidism. Eur .J.Endocrinol. 2020;183(1):G33–G39.
Pal R, Banerjee M. COVID 19 and the endocrine system: exploring the unexplored. J. Endocrinol. Invest. 2020;43(7):1027–1031.
Perez-Moreiras J.V., Gomez-Reino J.J., Maneiro J.R., et al. Efficacy of Tocilizumab in patients with moderate-to-severe corticosteroid-resistant graves orbitopathy: a randomized clinical trial. Am.J.Ophthalmol. 2018;195:181–190.
Vrachimis A, Iacovou I, Giannoula E, Giovanella L. Endocrinology in the time of COVID-19: management of thyroid nodules and cancer. Eur. J. Endocrinol. 2020;183(1):G41–G48.
